Vitamin D Deficiency Participates in Depression of Patients with Diabetic Peripheral Neuropathy by Regulating the Expression of Pro-Inflammatory Cytokines
Jingjing Zhou,Dongfeng Li,Youmin Wang
DOI: https://doi.org/10.2147/ndt.s442654
IF: 2.989
2024-02-28
Neuropsychiatric Disease and Treatment
Abstract:Jingjing Zhou, 1, 2 Dongfeng Li, 2 Youmin Wang 1 1 Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230001, People's Republic of China; 2 Department of Endocrinology, The Second People's Hospital of Lu'an, Affiliated Hospital of West Anhui Health Vocational College, Lu'an, Anhui, 237000, People's Republic of China Correspondence: Youmin Wang, Email Objective: Vitamin D deficiency is associated with patients with diabetic peripheral neuropathy (DPN), and low levels of vitamin D are common in patients with depression. Depression is common in DPN patients and the definite pathogenesis remains unclear. This study aimed to determine vitamin D deficiency in the onset of depression in DPN and evaluate the effect of vitamin D supplementation on depression. Methods: A total of 192 patients with DPN were enrolled in this study. Clinical and laboratory information was collected. Chemiluminescent immunoassay was used to measure the level of 25(OH)D. Enzyme-linked immunosorbent assay was employed to measure the concentrations of interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), and IL-17A. Subjects with low 25(OH)D received 5000IU vitamin D daily for 12 weeks. Depression scores and levels of 25(OH)D, IL-1β, TNF-α, and IL-17A were re-evaluated after supplementation. Results: The incidence of vitamin D deficiency and depression was high in DPN patients. Compared with vitamin D sufficient participants, Hamilton Depression Rating Scale (HAMD) scores and the levels of inflammatory markers IL-1β, TNF-α, and IL-17A were significantly higher in insufficient group (all p< 0.05). HAMD score, IL-1β, TNF-α, and IL-17A were negatively correlated with 25(OH)D (all p< 0.05). A linear relationship existed among IL-1β, TNF-α, IL-17A, and 25(OH)D (p< 0.05). HAMD scores, IL-1β, TNF-α, and IL-17A were all reduced significantly after supplementation of vitamin D (p< 0.05). Binary logistic analysis revealed that vitamin D insufficiency was an independent risk factor for depression in patients with DPN. Receiver operating characteristic (ROC) curve analysis showed a high sensitivity (87.20%) of 25(OH)D in discriminating DPN patients with depression. Conclusion: Vitamin D deficiency participated in occurrence of depression in DPN patients and could be mediated, at least in part, by upregulation of pro-inflammatory cytokines. Vitamin D supplementation may be effective in improving depressive symptoms in DPN patients. Keywords: vitamin D, depression, diabetic peripheral neuropathy, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-17A Diabetic peripheral neuropathy (DPN) is a very frequent complication of diabetes, affecting up to 50% of diabetes subjects over their lifetime. Patients with DPN may suffer from neuropathic pain, diabetic foot ulceration, and are at high risk of lower-extremity amputations. Older age, duration of diabetes, poor glycaemic control, patient's height, male gender, hypertension, hyperlipidaemia, and certain ethnicities are the major risk factors for DPN. 1 Neuropathic pain may lead to the deterioration of the general health status of diabetic patients, resulting in functional and emotional restrictions, alteration of physical activity and social implications. 2 The most common mental disorder among diabetic patients is low mood, ultimately leading to depression. Significant depressive symptoms are found in patients with DPN compared to subjects without neurological complications. 3 Clinical measurements of DPN, for instance, the neuropathy disability score and the vibration perception threshold, have been proven to be independently associated with Hospital Anxiety and Depression Scale (HADS). 4 Furthermore, symptoms of DPN, including reduced foot sensation, unsteadiness, and pain, are also related to depression, and severe symptoms are associated with more significant depression scores. 4,5 Vitamin D is known as a steroid hormone that plays an important role in bone mineral metabolism, participating in calcium, phosphorus metabolism, and skeletal homeostasis. In addition to bone metabolism-related diseases, vitamin D deficiency also participates in the pathologies of many clinical conditions such as cancer, infectious diseases, multiple sclerosis, and cardiovascular diseases. 6 Vitamin D deficiency is also considered to be a potential modifiable risk factor in DPN patients. Recent studies suggest that vitamin D deficiency is an independent risk factor for painful DPN, and vitamin D supplementation can improve pain scores in patients with painful DPN. 7,8 On the other hand, vitamin D deficiency is related to brain function and d -Abstract Truncated-
psychiatry,clinical neurology